Skip to main content
Clinical Trials/KCT0006113
KCT0006113
Completed
未知

Pragmatic randomized controlled trial of non-pharmacological treatment for lumbar disc herniation : A pilot study

Jaseng Hospital of Korean Medicine0 sites30 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of the musculoskeletal system and connective tissue
Sponsor
Jaseng Hospital of Korean Medicine
Enrollment
30
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
June 28, 2022
Last Updated
3 years ago
Study Type
Interventional Study
Sex
All

Investigators

Sponsor
Jaseng Hospital of Korean Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\. Numeric rating scale (NRS) score of radiating pain 5 or more for recent 3 serial days.
  • 2\. Onset time of radiating pain occurred within 12 weeks.
  • 3\. Radiologically diagnosed with lumbar disc herniation in lumbar spine magnetic resonance imaging (L\-spine MRI)
  • 4\. 19\-70 years old
  • 5\. participants who agreed and signed informed consent form

Exclusion Criteria

  • 1\. Spine metastasis of cancer, acute fracture of spine, or spine dislocation
  • 2\. Progressive neurologic deficits or severe neurologic deficits
  • 3\. Soft tissue diseases that can induce low back pain(ie. cancer, fibromyalgia, rheumatoid arthritis, gout,etc)
  • 4\. Presence of chronic underlying disease which can interfere the efficacy or interpretation (ie. stroke, myocardial infarct, kidney disease, dementia, diabetic neuropathy, epilepsy, etc)
  • 5\. Concurrent use of steroids, immunosuppressants, orpsychotropic medications or any other medication that can interrupt the study result
  • 6\. Hemorrhagic disease, severe diabetes or taking anticoagulant drug
  • 7\. Participants who took NSAIDs or pharmacopuncture within 1 week
  • 8\. Pregnant or lactating women
  • 9\. Participants who had undergone lumbar surgery within 3 months
  • 10\. Participants who had participated in other clinical trial within 1 month, or have plan for participation in other trial during follow up period of this trial

Outcomes

Primary Outcomes

Not specified

Similar Trials